Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Clinical Nephrology
|
January 1, 1994
Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies
M J Mihatsch, T Antonovych, S O Bohman, et al.
Diabetes Care
|
June 1, 1993
Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients
R G Burcelin, M Eddouks, M Beylot, et al.
The Journal of Nutrition, Health & Aging
|
October 8, 2013
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting
P H Robert, A Konig, S Andrieu, et al.
Journal of Viral Hepatitis
|
August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
S Pianko, S Zeuzem, W-L Chuang, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G R Foster, S Zeuzem, S Pianko, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Clinical Nephrology
|
January 1, 1994
Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies
M J Mihatsch, T Antonovych, S O Bohman, et al.
Diabetes Care
|
June 1, 1993
Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients
R G Burcelin, M Eddouks, M Beylot, et al.
The Journal of Nutrition, Health & Aging
|
October 8, 2013
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting
P H Robert, A Konig, S Andrieu, et al.
Journal of Viral Hepatitis
|
August 7, 2012
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
S Pianko, S Zeuzem, W-L Chuang, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G R Foster, S Zeuzem, S Pianko, et al.
Page
of 4